|
Index of reports
> Cases resulting in a serious event (8)
Below is the selection of adverse event reports related to Cervidil (Dinoprostone Vaginal) that includes cases resulting in a serious event.
Adverse event in 26 year old female receiving Cervidil (Dinoprostone Vaginal)
Reported by a consumer/non-health professional from United States on 2007-07-20
Patient: 26 year old female
Adverse reactions / side effects: Rubella Antibody Positive, Inappropriate Schedule of Drug Administration, Drug Dose Omission, Drug Exposure During Pregnancy, Heart Rate Increased, Amniocentesis Abnormal, Pregnancy
Suspect drug(s):
Cervidil
Claravis
Dosage: 40 mg, bid, oral
Administration route: Oral
Start date: 2006-02-07
End date: 2006-08-13
Ortho TRI-Cyclen LO
Dosage: 1 tablet, qd, oral
Administration route: Oral
Indication: Oral Contraception
Other drugs received by patient: Chitosan (Poliglusam); Isotrim (Sulfamethoxazole, Trimethoprim); Vita-PAK
Adverse event in 30 year old female receiving Cervidil (Dinoprostone Vaginal)
Reported by a individual with unspecified qualification from United Kingdom on 2007-07-06
Patient: 30 year old female, weighing 71.5 kg (157.3 pounds)
Adverse reactions / side effects: Postpartum Haemorrhage, Caesarean Section, Apgar Score LOW, Body Temperature Increased, Drug Exposure During Pregnancy, Foetal Heart Rate Deceleration, Uterine Atony, Foetal Heart Rate Abnormal, Tachycardia Foetal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Cervidil (Dinoprostone Vaginal)
Other drugs received by patient: Zolpidem Tartrate; Tylenol (Caplet); Intravenous Fluids; Epidural OR Regional Anesthesia; Oxygen
Adverse event in male receiving Cervidil (Dinoprostone Vaginal)
Reported by a individual with unspecified qualification from United Kingdom on 2007-07-06
Patient: male, weighing 2.5 kg (5.4 pounds)
Adverse reactions / side effects: Apgar Score LOW, Caesarean Section, Drug Exposure During Pregnancy, Foetal Heart Rate Disorder, PRE-Eclampsia, Tachycardia Foetal
Adverse event resulted in: hospitalization
Suspect drug(s):
Cervidil
Dosage: 10 mg once transplacental
Indication: Labour Induction
Start date: 2006-12-27
End date: 2006-12-27
Cervidil
Dosage: 10 mg once transplacental
Indication: Uterine Cervix Dilation Procedure
Start date: 2006-12-27
End date: 2006-12-27
Other drugs received by patient: Zolpidem Tartrate; Tylenol (Caplet); Intravenous Fluids; Epidural OR Regional Anesthesia; Oxygen
Adverse event in 30 year old female receiving Cervidil (Dinoprostone Vaginal)
Reported by a individual with unspecified qualification from United Kingdom on 2007-06-27
Patient: 30 year old female, weighing 71.5 kg (157.3 pounds)
Adverse reactions / side effects: Placental Infarction, Uterine Atony, Haemoglobin Decreased, Caesarean Section, Haematocrit Decreased, Drug Exposure During Pregnancy, NO Therapeutic Response, Surgical Failure, PRE-Eclampsia
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Cervidil (Dinoprostone Vaginal)
Other drugs received by patient: Zolpidem Tartrate; Tylenol (Caplet)
Adverse event in female receiving Cervidil (Dinoprostone Vaginal)
Reported by a health professional (non-physician/pharmacist) from France on 2007-06-04
Patient: female
Adverse reactions / side effects: Vomiting, Nuclear Magnetic Resonance Imaging Brain Abnormal, Meningism, Postictal State, Convulsion, Reversible Posterior Leukoencephalopathy Syndrome, Drug Exposure During Pregnancy, Tetanus, Tongue Biting, Musculoskeletal Stiffness
Adverse event resulted in: hospitalization
Suspect drug(s):
Cervidil
Dosage: 10 mg once vg
Indication: Uterine Cervix Dilation Procedure
Start date: 2007-02-09
Syntocinon
Indication: Labour Induction
Start date: 2007-02-09
Other drugs received by patient: Salbutamol
Adverse event in female receiving Cervidil (Dinoprostone Vaginal)
Reported by a individual with unspecified qualification from United Kingdom on 2007-05-23
Patient: female
Adverse reactions / side effects: Reversible Posterior Leukoencephalopathy Syndrome, Nuclear Magnetic Resonance Imaging Brain Abnormal, Meningism, Convulsion
Adverse event resulted in: hospitalization
Suspect drug(s):
Cervidil
Dosage: 10 mg once vg
Indication: Cervix Disorder
Start date: 2007-02-09
Syntocinon
Indication: Labour Induction
Start date: 2007-02-09
Other drugs received by patient: Salbutamol
Adverse event in female receiving Cervidil (Dinoprostone Vaginal)
Reported by a health professional (non-physician/pharmacist) from Canada on 2007-03-09
Patient: female
Adverse reactions / side effects: Caesarean Section, Drug Exposure During Pregnancy, Premature Separation of Placenta
Adverse event resulted in: hospitalization
Suspect drug(s):
Cervidil (Dinoprostone Vaginal)
Adverse event in female receiving Cervidil (Dinoprostone Vaginal)
Reported by a health professional (non-physician/pharmacist) from Canada on 2007-03-09
Patient: female
Adverse reactions / side effects: Premature Separation of Placenta
Suspect drug(s):
Cervidil (Dinoprostone Vaginal)
|
